These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 31227936)
61. Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat. Yao L; Mustafa N; Tan EC; Poulsen A; Singh P; Duong-Thi MD; Lee JXT; Ramanujulu PM; Chng WJ; Yen JJY; Ohlson S; Dymock BW J Med Chem; 2017 Oct; 60(20):8336-8357. PubMed ID: 28953386 [TBL] [Abstract][Full Text] [Related]
62. Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms. Bhagwat N; Koppikar P; Keller M; Marubayashi S; Shank K; Rampal R; Qi J; Kleppe M; Patel HJ; Shah SK; Taldone T; Bradner JE; Chiosis G; Levine RL Blood; 2014 Mar; 123(13):2075-83. PubMed ID: 24470592 [TBL] [Abstract][Full Text] [Related]